To view the complete article click here (pdf format)

Cancer pain is highly prevalent, with 70% to 90% of patients experiencing clinically significant pain at some time in their cancer journey. Fortunately, for the vast majority of such patients, the application of an analgesic strategy results in good control of pain, through use of medications available at the local pharmacy. Steady, baseline cancer pain is usually managed with protocols such as the World Health Organization’s analgesic ladder,1 which calls for pain medication to be administered around the clock in a scheduled manner.

To view the complete article click here (pdf format)